Verrica Pharmaceuticals Inc. (VRCA) income statement
VRCANasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.74−0.14 (-5.03%)
Close on Nov 20, 2026Market cap $47.07MP/E –Yield –
Verrica Pharmaceuticals Inc. financial ratios
See a number that looks wrong?